Ankin Law News
Friday, May 10, 2013: Josh Rudofi will be filing an Appellate Brief in Dig Right In Landscaping v. Jose Nunez on behalf of Jose Nunez.
Wednesday, April 24, 2013: Scott Goldstein will be speaking as a guest lecturer at John Marshall Law School in the Workers Compensation class.
Wednesday, April 17, 2013: Josh Rudolfi attended Artex Risk Solutions Mock Trial at The Witt. (read more...)
November 30, 2012: Scott Goldstein of Ankin Law Office
was highlighted in a "Making Chicago Great" feature
on WCIU Channel 26 in Chicago.
November, 2012: A client of Howard Ankin knitted him a
blanket as a special thank you after a multiple
6 figure settlement.
RECENT BLOG POSTS
Fingerprinting has become the gold standard amongst law enforcement, schools, religious institutions and community groups...
We most often think about sexual harassment in the workplace and envision a corporate boss...
As more and more people hit the road for summer vacations, graduations or family outings,...
Oral Sodium Phosphate (OSP)
Illinois Oral Sodium Phosphate Lawsuit Attorneys
Chicago Oral Sodium Phosphate Litigation Lawyers
Oral Sodium Phosphate (OSP), a laxative used in connection with a colonoscopy, has been associated with kidney damage and kidney failure, especially in patients over the age of 55. The Chicago unsafe pharmaceutical attorneys at Ankin Law Offices, LLC have significant experience representing clients in product liability lawsuits, including class action cases and unsafe pharmaceutical litigation. If you or someone you love has suffered kidney damage or injury as a result of taking Visicol or other form of OSP in connection with a colonoscopy, our skilled Illinois unsafe pharmaceutical attorneys can help you with any product liability lawsuit you may have.
What Is Oral Sodium Phosphate?
OSP is the main ingredient in a type of laxative, marketed under the names Fleet Phospho-soda, Fleet ACCU-PREP, Visicol, and OsmoPrep, that is used to cleanse the bowels prior to a colonoscopy. The drug works by using sodium to draw water into the bowels and induce diarrhea.
What Are the Reported Problems With OSP?
OSP has been associated with an increased risk of kidney damage, especially in patients over the age of 55 – the group of patients most likely to use the drug in connection with a colonoscopy. The compound’s phosphate levels are considered the primary cause of the side effects, including acute kidney phosphate nephropathy, which is a form of kidney injury that occurs when deposits of calcium-phosphate crystallizes in the kidney and block the kidneys’ ability to filter blood. In severe cases, acute renal failure can occur, which is a permanent condition requiring regular dialysis.
Symptoms of acute phosphate nephropathy can include abnormal heart rate, fatigue, high blood pressure and difficulty urinating. If you have taken OSP and experience these symptoms, you should seek immediate medical attention.
What Is the Status of OSP?
In 2008, the U.S. Food and Drug Administration (FDA) ordered the manufacturers of OSP to include a “black box” warning on the drug’s label warning patients of the risk of acute kidney phosphate nephropathy and other kidney injuries. The FDA, nonetheless, deems the compound to be safe for use as an over-the-counter laxative.
If you or a loved one has suffered acute kidney phosphate nephropathy or other kidney injury after taking OSP in connection with a colonoscopy, you may be entitled to compensation in an unsafe pharmaceutical product liability claim. Contact the skilled Chicago unsafe pharmaceutical drug law firm of Ankin Law Offices at (800) 442-6546 to schedule a free consultation to discuss your unsafe pharmaceutical lawsuit.
You Might Also Be Interested In: